Tal Grenader

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial

Tal Grenader, Thomas K. Waddell, Clare Peckitt et al. · Annals of Oncology · 2016 · 103 citations · Full text

Medicine, Hematology, Oncology +10

BRCA Mutation Status and Determinant of Outcome in Women with Recurrent Epithelial Ovarian Cancer Treated with Pegylated Liposomal Doxorubicin

Tamar Safra, Lucia Borgato, Maria Ornella Nicoletto et al. · Molecular Cancer Therapeutics · 2011 · 93 citations

Medicine, Gynecology, Oncology +15

Neutrophil-Lymphocyte Ratio: Prognostic Impact in Heart Surgery. Early Outcomes and Late Survival

Shuli Silberman, Ulfat Abu-Yunis, Rachel Tauber et al. · The Annals of Thoracic Surgery · 2017 · 85 citations

Medicine, Hematology, Surgery +16

Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies

Tal Grenader, Stephen Nash, Yevgeni Plotkin et al. · Annals of Oncology · 2015 · 71 citations · Full text

Medicine, Oncology, Pharmacology +11

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study

Tal Grenader, Stephen Nash, Richard Adams et al. · British Journal of Cancer · 2016 · 70 citations · Full text

Medicine, Hematology, Oncology +15